Interferon-Albumin Conjugate with Conserved Biological Activity

References

1. Baron S., Buckler C. E., Friedman R. M., Mccloskey R. V. 1966; Role of interferon during viremia. I. Production of circulating interferon. Journal of Immunology 96:12–16
   [Google Scholar]
2. Cantell K., Pyhala L. 1973; Circulating interferon in rabbits after administration of human interferon by different routes. Journal of General Virology 20:97–104
   [Google Scholar]
3. Carlsson J., Drevin H., Axen R. 1978; Protein thiolation and reversible protein-protein conjugation. Biochemical Journal 173:723–737
   [Google Scholar]
4. Finter N. B. 1966; Interferon as an antiviral agent in vivo: quantitative and temporal aspects of the protection of mice against Semliki Forest virus. British Journal of Experimental Pathology 47:361–371
   [Google Scholar]
5. Reuveny S., Bino T., Rosenberg H., Traub A., Mizrahi A. 1980; Pilot plant scale production of human lymphoblastoid interferon. Third General Meeting of ESACT, Oxford 1979, Develop. Biol. Standard no. 46, pp 281–288 Basel: S. Karger;
   [Google Scholar]
6. Sterling K. 1951; The turnover rate of serum albumin in man as measured by l¹³¹-atbumin. Journal of Clinical Investigation 30:1228–1237
   [Google Scholar]
7. Strander H., Cantell K., Carlstrom G., Jakobsson P. A. 1973; Systematic administration of potent interferon to man. Journal of the National Cancer Institute 51:733–742
   [Google Scholar]